Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
3GTMS provides transportation management system software for shippers, brokers, and logistics service providers.
Snappt provides fraud detection and income verification software for multifamily property managers.
ZeroFox provides external cybersecurity solutions to help organizations identify, manage, and mitigate social media-based cyber threats.
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Udacity develops an online learning platform offering programs in artificial intelligence, machine learning, and robotics sector.
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Semperis is a developer of enterprise identity protection and cyber resilience for cross-cloud and hybrid environments.
Behavox is an AI-driven platform that enables you to aggregate, analyze, and act on your entire organization’s data.
Electric Hydrogen develops electrolyzer technologies to enable abundant, low-cost, and clean hydrogen to replace fossil fuels.
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.
Main Street Health is a supplier of value-based, care-focused healthcare services designed to address rural wellness challenges.
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Esme Learning is transforming the world's workforce for the Fourth Industrial Revolution using AI.
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.
Remodel Health delivers software to assist employers in managing health benefits and transitioning to ICHRA.
Phathom Pharmaceuticals is a biopharmaceutical company.
Hypercore provides a cloud-based platform that manages loan portfolios from origination through repayment.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
Hercules Capital has invested in 67 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hercules Capital's top investment sectors include Biotechnology, Pharmaceutical, Health Care, Software, Artificial Intelligence (AI). The firm invests across 41 different industry categories.
Among tracked funding rounds, Axsome Therapeutics received $570.0M in a Post-IPO Debt round. Hercules Capital's total known invested capital is $5.3B.
Hercules Capital's average investment size is $97.1M across its portfolio of 67 companies.
Recent Hercules Capital portfolio additions include 3Gtms, Snappt, ZeroFox, Alladapt Immunotherapeutics, Udacity. These companies were founded in 2020 or later.